Trials / Completed
CompletedNCT00195364
Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain
Long-Term Safety Study of Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 93 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate long-term safety of etanercept in patients with rheumatoid arthritis who successfully have completed open-label safety study 0881A1-301-EU
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etanercept |
Timeline
- Start date
- 2003-07-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2005-09-19
- Last updated
- 2009-06-04
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00195364. Inclusion in this directory is not an endorsement.